Literature DB >> 15184715

Drug-induced depression: a systematic review to inform clinical practice.

Scott B Patten1, Corrado Barbui.   

Abstract

BACKGROUND: Certain medications may contribute to the etiology of depressive symptoms and disorders. Research in this area, however, has been hampered by methodological and conceptual problems. This review had two objectives: to identify evidence linking medical drugs to depressive symptoms and disorders, and to summarize this evidence in a clinically meaningful way.
METHODS: Electronic literature searches were performed and studies were reviewed with reference to critical methodological features.
RESULTS: No medications causing the typical major depressive syndrome were identified. Evidence was found linking corticosteroids, interferon-alpha, interleukin-2, gonadotropin-releasing hormone agonists, mefloquine, progestin-releasing implanted contraceptives and propranolol to the etiology of atypical depressive syndromes.
CONCLUSIONS: A small number of drugs have been shown capable of inducing depressive symptoms. Drug-induced depression appears to differ symptomatically from classical major depression. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184715     DOI: 10.1159/000077739

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  20 in total

Review 1.  Practical considerations for the treatment of elderly patients with migraine.

Authors:  Paola Sarchielli; Maria Luisa Mancini; Paolo Calabresi
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Assessment of physical etiologies for mood and anxiety disorders in structured diagnostic interviews.

Authors:  Scott B Patten; Jeanne V A Williams
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-04-21       Impact factor: 4.328

3.  The association between use of cardiovascular drugs and antidepressants: a nationwide register-based study.

Authors:  Kristina Johnell; Johan Fastbom
Journal:  Eur J Clin Pharmacol       Date:  2008-08-07       Impact factor: 2.953

4.  Effect of CBT on Depressive Symptoms in Methadone Maintenance Patients Undergoing Treatment for Hepatitis C.

Authors:  Susan E Ramsey; Patricia A Engler; Michael D Stein; Richard A Brown; Patricia Cioe; Christopher W Kahler; Kittichai Promrat; Jennifer Rose; Jennifer Anthony; David A Solomon
Journal:  J Addict Res Ther       Date:  2011-05-13

Review 5.  Pharmacological management of depression in patients with cancer: practical considerations.

Authors:  Riccardo G V Torta; Valentina Ieraci
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

6.  Prevalence of depression and its related factors among Chinese women with breast cancer.

Authors:  Xiaoli Chen; Ying Zheng; Wei Zheng; Kai Gu; Zhi Chen; Wei Lu; Xiao Ou Shu
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

7.  Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H(2) receptor antagonists in community-dwelling older persons: cross-sectional analysis of a population-based cohort.

Authors:  Liang Feng; Chay-Hoon Tan; Reshma A Merchant; Tze-Pin Ng
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

8.  Adolescent Emotional Pathology and Lifetime History of Alcohol or Drug Use With and Without Comorbid Tobacco Use.

Authors:  Cheng-Wei I Chuang; Connie Chan; Adam M Leventhal
Journal:  J Dual Diagn       Date:  2016

Review 9.  Depressogenic effects of medications: a review.

Authors:  Christopher M Celano; Oliver Freudenreich; Carlos Fernandez-Robles; Theodore A Stern; Mario A Caro; Jeff C Huffman
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

10.  Finasteride induced depression: a prospective study.

Authors:  Babak Rahimi-Ardabili; Ramin Pourandarjani; Peiman Habibollahi; Amir Mualeki
Journal:  BMC Clin Pharmacol       Date:  2006-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.